Gain Therapeutics Price Target Maintained With a $8.00/Share by HC Wainwright & Co.

Gain Therapeutics目标价维持在每股8.00美元，由HC Wainwright& Co.评定。

道琼斯 · 10/09 07:24 · 评级/大行评级

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.